Impact of Cipepofol versus Propofol on Long-Term Cardiovascular Outcomes After TAVR: An Extended Follow-Up of a Randomized Trial
Tingting Ni, Yantian Lv, Laiying Zhou, Jing Yu, Xincheng Tao, Han Cao, Yuanyuan Yao, Min Yan · 2026
Read Impact of Cipepofol versus Propofol on Long-Term Cardiovascular Outcomes After TAVR: An Extended Follow-Up of a Randomized Trial by Tingting Ni, Yantian Lv, Laiying Zhou, Jing Yu, Xincheng Tao, Han Cao, Yuanyuan Yao, Min Yan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13594509.txt.
Description
Tingting Ni and colleagues extended a valve trial follow-up in 2026. The trial compared two anesthesia drugs during a heart valve procedure. The procedure threads a new aortic valve in through the leg. Patients under general anesthesia risk unstable blood pressure. An earlier trial found steadier pressure with the newer drug. Whether that steadiness improves later outcomes was unknown. The team rechecked patients at thirty days and one year. The main outcome mixed death, stroke, kidney injury, and heart events.
At one year, the combined outcome favored the newer drug numerically. The gap did not reach firm statistical proof. One part did differ clearly. New irregular heart rhythm arose less often with the newer drug. Earlier time points showed the same mild pattern. The authors label all these checks exploratory. Small numbers and many comparisons limit certainty. Findings apply only to general anesthesia cases, they stress.
Catalog record
| CREATOR | Tingting Ni, Yantian Lv, Laiying Zhou, Jing Yu, Xincheng Tao, Han Cao, Yuanyuan Yao, Min Yan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |